•The
model provides global planning and tracking -
country-site-patient level through bulk, to:
–-
Manage multiple study treatment arms to plan
site and pipeline inventory
- Track
each actual patient / each visit and drug usage
–-
Plan and distribute placebo & comparator drug.
–It
also helps to synchronize timing and quantity
across the pipeline for multiple what-if
scenarios, by:
–-
Providing separate blinded / unblinded outputs
for analytical needs
–-
Adjusting operational parameters at any stage in
the pipeline and review the impact from bulk
production to the country sites.